Total Valuation
Cardio Diagnostics Holdings has a market cap or net worth of $5.80M. The enterprise value is -$2.44T.
Market Cap$5.80M
Enterprise Value-$2.44T
Share Statistics
Cardio Diagnostics Holdings has 2,959,469 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,959,469
Owned by Insiders2.72%
Owned by Institutions0.47%
Financial Efficiency
Cardio Diagnostics Holdings’s return on equity (ROE) is -0.93 and return on invested capital (ROIC) is -84.55%.
Return on Equity (ROE)-0.93
Return on Assets (ROA)-0.84
Return on Invested Capital (ROIC)-84.55%
Return on Capital Employed (ROCE)-0.91
Revenue Per Employee988.33
Profits Per Employee-433.21K
Employee Count15
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cardio Diagnostics Holdings is ―. Cardio Diagnostics Holdings’s PEG ratio is 0.01.
PE Ratio―
PS Ratio320.16
PB Ratio0.68
Price to FCF-0.80
Price to Operating Cash Flow-1.08
PEG Ratio0.01
Income Statement
In the last 12 months, Cardio Diagnostics Holdings had revenue of 14.82K and earned -6.50M in profits. Earnings per share was -3.71.
Revenue14.82K
Gross Profit14.82K
Operating Income-6.48M
Pretax Income-6.50M
Net Income-6.50M
EBITDA-6.09M
Earnings Per Share (EPS)-3.71
Cash Flow
In the last 12 months, operating cash flow was -5.66M and capital expenditures -181.61K, giving a free cash flow of -5.84M billion.
Operating Cash Flow-5.66M
Free Cash Flow-5.84M
Free Cash Flow per Share-1.97
Dividends & Yields
Cardio Diagnostics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.64
52-Week Price Change-53.18%
50-Day Moving Average1.89
200-Day Moving Average2.17
Relative Strength Index (RSI)59.95
Average Volume (3m)30.89K
Important Dates
Cardio Diagnostics Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Cardio Diagnostics Holdings as a current ratio of 9.79, with Debt / Equity ratio of 4.98%
Current Ratio9.79
Quick Ratio9.79
Debt to Market Cap0.06
Net Debt to EBITDA0.73
Interest Coverage Ratio-438.08
Taxes
In the past 12 months, Cardio Diagnostics Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cardio Diagnostics Holdings EV to EBITDA ratio is -0.05, with an EV/FCF ratio of -0.06.
EV to Sales22.35
EV to EBITDA-0.05
EV to Free Cash Flow-0.06
EV to Operating Cash Flow-0.06
Balance Sheet
Cardio Diagnostics Holdings has $5.59M in cash and marketable securities with $369.70K in debt, giving a net cash position of $5.22M billion.
Cash & Marketable Securities$5.59M
Total Debt$369.70K
Net Cash$5.22M
Net Cash Per Share$1.76
Tangible Book Value Per Share$3.48
Margins
Gross margin is -555.03%, with operating margin of -43737.46%, and net profit margin of -43832.49%.
Gross Margin-555.03%
Operating Margin-43737.46%
Pretax Margin-43832.49%
Net Profit Margin-43832.49%
EBITDA Margin-41047.14%
EBIT Margin-43732.65%
Analyst Forecast
The average price target for Cardio Diagnostics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-25.92%
EPS Growth Forecast37.50%